Abstract
Cerebral ischemia is characterized by obvious inflammatory cell aggregations, up-regulation of cytokine expression, and increased expression of intercellular adhesion molecules. Like systemic bacterial infections, cerebral injury is also associated with innate immunity, a specific immunologic response that utilizes Toll-like receptors (TLRs). The involvement of TLRs in cerebral ischemia is now being confirmed using animal models. Recent reports reveal that mice that lack TLR2 and TLR4 show improved stroke outcomes and that TLR2 and 4 may contribute to neuronal injury that occurs after cerebral ischemia. In this review, we have summarized these recent reports concerning the association of TLRs with cerebral ischemia.
Keywords: Cerebral ischemia, inflammation, innate immunity, mouse, middle cerebral artery occlusion (MCAO), Toll-like receptor (TLR), HMGB1, HSP60, IFN-, IRF3, lipopolysaccharide (LPS), microglia, middle cerebral artery occlusion, MMP, MyD88, neuron, NF-B, pathogenassociated molecular patterns (PAMPs), pattern-recognition receptor (PPR), TLR2, TLR3, TLR4, TLR9, TNF-, Toll/IL-1 receptor (TIR), TRIF
Central Nervous System Agents in Medicinal Chemistry
Title: Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage
Volume: 11 Issue: 2
Author(s): Junya Hamanaka and Hideaki Hara
Affiliation:
Keywords: Cerebral ischemia, inflammation, innate immunity, mouse, middle cerebral artery occlusion (MCAO), Toll-like receptor (TLR), HMGB1, HSP60, IFN-, IRF3, lipopolysaccharide (LPS), microglia, middle cerebral artery occlusion, MMP, MyD88, neuron, NF-B, pathogenassociated molecular patterns (PAMPs), pattern-recognition receptor (PPR), TLR2, TLR3, TLR4, TLR9, TNF-, Toll/IL-1 receptor (TIR), TRIF
Abstract: Cerebral ischemia is characterized by obvious inflammatory cell aggregations, up-regulation of cytokine expression, and increased expression of intercellular adhesion molecules. Like systemic bacterial infections, cerebral injury is also associated with innate immunity, a specific immunologic response that utilizes Toll-like receptors (TLRs). The involvement of TLRs in cerebral ischemia is now being confirmed using animal models. Recent reports reveal that mice that lack TLR2 and TLR4 show improved stroke outcomes and that TLR2 and 4 may contribute to neuronal injury that occurs after cerebral ischemia. In this review, we have summarized these recent reports concerning the association of TLRs with cerebral ischemia.
Export Options
About this article
Cite this article as:
Hamanaka Junya and Hara Hideaki, Involvement of Toll-like Receptors in Ischemia-induced Neuronal Damage, Central Nervous System Agents in Medicinal Chemistry 2011; 11 (2) . https://dx.doi.org/10.2174/187152411796011312
DOI https://dx.doi.org/10.2174/187152411796011312 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Contrast Echocardiography: An Update on Clinical Applications
Current Pharmaceutical Design A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Letters in Organic Chemistry In Search for the Troponin of the Kidney
Current Medicinal Chemistry Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters Radiofluorinated Carbohydrates for Positron Emission Tomography
Current Topics in Medicinal Chemistry Nonsteroidal Anti-Inflammatory Drugs: Exploiting Bivalent COXIB/ TP Antagonists for the Control of Cardiovascular Risk
Current Medicinal Chemistry Drugs Interfering with Apoptosis in Breast Cancer
Current Pharmaceutical Design Vascular Endothelial Growth Factor and Angiopoietins in Neurovascular Regeneration and Protection Following Stroke
Current Neurovascular Research Functional and Molecular Ultrasound Imaging: Concepts and Contrast Agents
Current Medicinal Chemistry MicroRNA Expression in Coronary Artery Disease
MicroRNA Magnetic Resonance Perfusion Imaging Provides a Significant Tool for the Identification of Cardioembolic Stroke
Current Neurovascular Research Flavonoids and Anthranquinones as Xanthine Oxidase and Monoamine Oxidase Inhibitors: A New Approach Towards Inflammation and Oxidative Stress
Current Topics in Medicinal Chemistry Review of the Biological Activity of Maslinic Acid
Current Drug Targets Relationship Between Cigarette Smoking and Other Coronary Risk Factors in Atherosclerosis: Risk of Cardiovascular Disease and Preventive Measures
Current Pharmaceutical Design Neutrophil Gelatinase-associated Lipocalin as a Marker of Postoperative Acute Kidney Injury Following Cardiac Surgery in Patients with Preoperative Kidney Impairment
Cardiovascular & Hematological Disorders-Drug Targets Erythropoietin: New Horizon in Cardiovascular Medicine
Recent Patents on Cardiovascular Drug Discovery Inflammatory Mediators and the Failing Heart: A Translational Approach
Current Molecular Medicine Green Tea Catechins and Cardiovascular Health: An Update
Current Medicinal Chemistry Experimental Model Considerations for the Study of Protein-Energy Malnutrition Co-Existing with Ischemic Brain Injury
Current Neurovascular Research <i>Scutellaria baicalensis</i> Extract-phospholipid Complex: Preparation and Initial Pharmacodynamics Research in Rats
Current Pharmaceutical Biotechnology